Clinical Trial Update: Measuring Gait And Self-Reported Pain In Patients With Osteoarthritis Of The Knee Using Placebo/Oxycodone/Celecoxib. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing gait and self-reported pain in knee osteoarthritis treated with placebo, oxycodone, or celecoxib; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Celecoxib (Celecoxib)
• Oxycodone (oxycodone)

Snippet

Sponsor: Pfizer | Conditions: Osteoarthritis | Phase 4 | Status: TERMINATED | Results posted: 2021-04-14